BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 29872378)

  • 1. Comparison of a Rat Primary Cell-Based Blood-Brain Barrier Model With Epithelial and Brain Endothelial Cell Lines: Gene Expression and Drug Transport.
    Veszelka S; Tóth A; Walter FR; Tóth AE; Gróf I; Mészáros M; Bocsik A; Hellinger É; Vastag M; Rákhely G; Deli MA
    Front Mol Neurosci; 2018; 11():166. PubMed ID: 29872378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of brain capillary endothelial cell-based and epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) cell-based surrogate blood-brain barrier penetration models.
    Hellinger E; Veszelka S; Tóth AE; Walter F; Kittel A; Bakk ML; Tihanyi K; Háda V; Nakagawa S; Duy TD; Niwa M; Deli MA; Vastag M
    Eur J Pharm Biopharm; 2012 Oct; 82(2):340-51. PubMed ID: 22906709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rat brain endothelial cell lines for the study of blood-brain barrier permeability and transport functions.
    Roux F; Couraud PO
    Cell Mol Neurobiol; 2005 Feb; 25(1):41-58. PubMed ID: 15962508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood-brain barrier model for drug permeability studies.
    Eigenmann DE; Xue G; Kim KS; Moses AV; Hamburger M; Oufir M
    Fluids Barriers CNS; 2013 Nov; 10(1):33. PubMed ID: 24262108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A face-to-face comparison of claudin-5 transduced human brain endothelial (hCMEC/D3) cells with porcine brain endothelial cells as blood-brain barrier models for drug transport studies.
    Gericke B; Römermann K; Noack A; Noack S; Kronenberg J; Blasig IE; Löscher W
    Fluids Barriers CNS; 2020 Aug; 17(1):53. PubMed ID: 32843059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similarities and differences in the localization, trafficking, and function of P-glycoprotein in MDR1-EGFP-transduced rat versus human brain capillary endothelial cell lines.
    Gericke B; Borsdorf S; Wienböker I; Noack A; Noack S; Löscher W
    Fluids Barriers CNS; 2021 Aug; 18(1):36. PubMed ID: 34344390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a Primate Blood-Brain Barrier Co-Culture Model Prepared from Primary Brain Endothelial Cells, Pericytes and Astrocytes.
    Watanabe D; Nakagawa S; Morofuji Y; Tóth AE; Vastag M; Aruga J; Niwa M; Deli MA
    Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of an iPSC-based barrier model for blood-brain barrier investigations using the SBAD0201 stem cell line.
    Ozgür B; Puris E; Brachner A; Appelt-Menzel A; Oerter S; Balzer V; Holst MR; Christiansen RF; Hyldig K; Buckley ST; Kristensen M; Auriola S; Jensen A; Fricker G; Nielsen MS; Neuhaus W; Brodin B
    Fluids Barriers CNS; 2023 Dec; 20(1):96. PubMed ID: 38115090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Triple Culture Model of the Blood-Brain Barrier Using Porcine Brain Endothelial cells, Astrocytes and Pericytes.
    Thomsen LB; Burkhart A; Moos T
    PLoS One; 2015; 10(8):e0134765. PubMed ID: 26241648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Culture-induced changes in mRNA expression levels of efflux and SLC-transporters in brain endothelial cells.
    Goldeman C; Ozgür B; Brodin B
    Fluids Barriers CNS; 2020 Apr; 17(1):32. PubMed ID: 32321539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Human in vitro Brain-blood Barrier Model from Induced Pluripotent Stem Cell-derived Endothelial Cells to Predict the in vivo Permeability of Drugs.
    Li Y; Sun X; Liu H; Huang L; Meng G; Ding Y; Su W; Lu J; Gong S; Terstappen GC; Zhang R; Zhang W
    Neurosci Bull; 2019 Dec; 35(6):996-1010. PubMed ID: 31079318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mRna expression and transport characterization of conditionally immortalized rat brain capillary endothelial cell lines; a new in vitro BBB model for drug targeting.
    Hosoya KI; Takashima T; Tetsuka K; Nagura T; Ohtsuki S; Takanaga H; Ueda M; Yanai N; Obinata M; Terasaki T
    J Drug Target; 2000; 8(6):357-70. PubMed ID: 11328662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
    Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
    Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-evaluation of the hCMEC/D3 based in vitro BBB model for ABC transporter studies.
    Balzer V; Poc P; Puris E; Martin S; Aliasgari M; Auriola S; Fricker G
    Eur J Pharm Biopharm; 2022 Apr; 173():12-21. PubMed ID: 35227855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functional in vitro model of rat blood-brain barrier for molecular analysis of efflux transporters.
    Perrière N; Yousif S; Cazaubon S; Chaverot N; Bourasset F; Cisternino S; Declèves X; Hori S; Terasaki T; Deli M; Scherrmann JM; Temsamani J; Roux F; Couraud PO
    Brain Res; 2007 May; 1150():1-13. PubMed ID: 17434463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A face-to-face comparison of the BBB cell models hCMEC/D3 and hBMEC for their applicability to adenoviral expression of transporters.
    Taggi V; Schäfer AM; Dolce A; Meyer Zu Schwabedissen HE
    J Neurochem; 2024 May; ():. PubMed ID: 38735840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Influence of Astrocytes on
    García-Salvador A; Domínguez-Monedero A; Gómez-Fernández P; García-Bilbao A; Carregal-Romero S; Castilla J; Goñi-de-Cerio F
    Altern Lab Anim; 2020 Jul; 48(4):184-200. PubMed ID: 33136430
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of Long-term In Vitro Lithium Exposure on mRNA Levels of Claudin-3, CYP1A1, ABCG2 and GSTM3 Genes in the hCMEC/D3 Human Brain Endothelial Cell Line.
    Shawahna R; Ganeshamoorthy K; Huilong L; Scherrmann JM; Couraud PO; Declèves X
    Eur J Drug Metab Pharmacokinet; 2017 Dec; 42(6):1013-1017. PubMed ID: 28367588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model.
    Ohtsuki S; Ikeda C; Uchida Y; Sakamoto Y; Miller F; Glacial F; Decleves X; Scherrmann JM; Couraud PO; Kubo Y; Tachikawa M; Terasaki T
    Mol Pharm; 2013 Jan; 10(1):289-96. PubMed ID: 23137377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of interleukin-6 on drug transporters and permeability in the hCMEC/D3 blood-brain barrier model.
    Simon F; Guyot L; Garcia J; Vilchez G; Bardel C; Chenel M; Tod M; Payen L
    Fundam Clin Pharmacol; 2021 Apr; 35(2):397-409. PubMed ID: 32757312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.